GlaxoSmithKline can now link up with product partners in days or weeks rather than months. Meteorologists will soon access libraries of weather data from across the globe through their browser in seconds. The aerospace and automotive industries can quickly deploy widespread teams to tackle complex problems.
These are the first impacts to spring from the SIMDAT project, a massive European research effort to bring grid technology to bear on the business world.
It could help improve car safety, reduce noise and vibrations in cars, usher in low-noise aircraft able to use short runways, promote faster and targeted drug discovery and development. It could enable better weather prediction and climate analysis.
This is just the beginning. SIMDAT has created a portfolio of tools for grid deployment in business environments, focusing initially on product development in four of the most demanding sectors in the world: pharmaceuticals, aerospace, automotive and meteorology.
“The industries we chose were quite different,” recalls Professor Dr Ulrich Trottenberg, director of Fraunhofer SCAI, coordinating partner of SIMDAT. “It was a particular strength of SIMDAT to aim at several industrial sectors to try to find out what can be done independent of the sector and what has to be done within the sector.”
SIMDAT applied their technology to meteorology to develop a way for researchers to access data anywhere in the world, from any weather service, using 11 pilot national weather agencies to establish and validate the system.
In pharmaceuticals, SIMDAT applied its portfolio of technologies to drug discovery, using grids to link research partners with GlaxoSmithKline. Typically, it could take months to get a partnership up and running. With the SIMDAT system, it takes days or weeks. Consider the savings when GlaxoSmithKline is known to spend €300,000 an hour on drug discovery research.
Intellectual property and security is one of the reasons it takes so long to set up partnerships in the pharmaceuticals sector, but the SIMDAT portfolio of tools carefully manages access to sensitive data, overcoming one of the major obstacles to rapid grid deployment.
Its ‘Pharma’ application is used for data-mining very large text and genome databases, looking at 3D structures for similarity and relations and context. “They are very intensive applications,” stresses Yvonne Havertz, Fraunhofer SCAI, SIMDAT project management.
In the aerospace application, SIMDAT tools allowed the integration of different research sites and partners. Each player could use their own tools and environment and still exchange data and services across the grid.
The underlying technology is unimportant to the users. SIMDAT transparently delivers the functionality. This enormously reduces costs, because engineers do not need to buy new software and there is direct support for the integration process; the SIMDAT grid solution does most of the grunt work.
The system does initially require integration between the engineers’ tools and the SIMDAT platform, but once that is accomplished, the platform handles all the management and execution of data and applications. It provides a way to integrate disparate systems quickly and securely.
The engineers and companies who tested the platform in the various application sectors are all very enthusiastic about the potential of the technology, “And they have also suggested areas that could be improved,” explains Clemens-August Thole, Fraunhofer SCAI, SIMDAT project coordinator.
SIMDAT’s impact went beyond the grid platform it developed. It also created new opportunities for existing products.
Taverna from IT Innovation and KDE from InforSense are two important applications in the pharmaceuticals sector. But these workflow tools also have an application in the automotive and aerospace industries. SIMDAT helped create markets for an existing product and a new solution for a current problem.
That is just one simple illustration of the range and impact of SIMDAT’s work. The project worked on grid standards, and developed a wide range of commercial opportunities, some of which are already being realised.
The SIMDAT project received funding from the ICT strand of the Sixth Framework Programme for research.
This is part two of a three-part series on SIMDAT. Part three will appear on 17 December.
Christian Nielsen | alfa
Researchers achieve HD video streaming at 10,000 times lower power
20.04.2018 | University of Washington
An AI that makes road maps from aerial images
18.04.2018 | Massachusetts Institute of Technology, CSAIL
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy